XORTX Therapeutics (XRTX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Corporate company logo of XORTX Therapeutics Inc (XRTX)

The price history of XORTX Therapeutics Inc. (XRTX) demonstrates an EV/EBITDA ratio of 0.00. The firm's environmental footprint is minimal, as drug trials are delegated to external centers. The business model relies on expanding its presence in the renal pathology therapy segment through B2B collaboration. Future capitalization growth is tied to the success of clinical tests, investor support, and the demand for metabolism correction agents.

XRTX XORTX Corp: Enterprise Value to EBITDA Ratio in the range 11/23/2025 - 11/15/2026

XORTX Therapeutics - analytical breakdowns and key metrics (XRTX)

- current price and projected stock value:
Initial company analysis:XORTX Therapeutics (XRTX)
Original product of xortx.com

To objectively measure the operational efficiency of XORTX Therapeutics Inc. (XRTX), it is necessary to strip away the impact of taxes and depreciation on net income. The EV/EBITDA trend allows for a comparison of the company's market value with its actual ability to generate cash flow, eliminating accounting distortions. For stable biotech management, this indicator confirms that the adaptation of clinical trials leads to value growth rather than the accumulation of hidden debt.

Competitor analysis for XORTX Therapeutics Inc.

EV/EBITDA Multiple ARGX (argenx.com)|Total Company Value to Operating Income Before Depreciation Ratio biontech.de (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ADMA Biologics Inc (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist Corp (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant, Inc.|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple grifols.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies Corp (ADPT)|Celldex Therapeutics, Inc. - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (auriniapharma.com)|BioCryst Pharmaceuticals Inc (BCRX) - Company Value to EBITDA|VERA: Enterprise Value to EBITDA Ratio|DNTH (Dianthus Therapeutics) - Enterprise Value to Operating Income Before Depreciation|PHVS: EV/EBITDA Multiple|ABCL (AbCellera Biologics Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio TRML|Company Value to EBITDA Intrexon PGEN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming Group N.V. (PHAR)|Enterprise Value to Operating Income Before Depreciation Ratio NKTR|EV/EBITDA Multiple UPB (Upstream Pharma)|Total Company Value to Operating Income Before Depreciation Ratio Zenas Biopharma, Inc. (ZBIO)|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Gossamer Corp (GOSS) - Enterprise Value to EBITDA Ratio|KALV (KalVista Pharmaceuticals Inc) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation SEPN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pieris Pharmaceuticals|Savara Inc (SVRA) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RIGL|Total Company Value to Operating Income Before Depreciation Ratio AnaptysBio Inc.|EV/EBITDA Multiple ATXS (Astria Therapeutics Inc)|enGene Holdings Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|RAPT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation JBIO (aerovatetx.com)|Aclaris (ACRS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Kyverna - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio TLSA|Company Value to EBITDA Cabaletta Bio CABA|EV/EBITDA Multiple VTYX|Theratechnologies (THTX) - Enterprise Value to EBITDA Multiple|Avalo Therapeutics - Enterprise Value to EBITDA Ratio|Eledon Pharmaceuticals (ELDN) - Company Value to EBITDA|Agenus, Inc - EV/EBITDA Multiple|Company Value to EBITDA climbbio.com|ZURA (Zura Bio Limited) - Enterprise Value to EBITDA Ratio|aTyr (ATYR) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio ADAG|IMA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Shattuck Therapeutics (STTK)|Enterprise Value to EBITDA Ratio Equillium EQ|Connect Biopharma Holdings Limited - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation IMUX|ATRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|inflarx.de (IFRX) - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation X4 Pharmaceuticals XFOR|ACET - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization celularity.com|INMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple BRNS|EV/EBITDA Multiple Kezar Life Sciences Inc (KZR)|EV/EBITDA Multiple SABS (SAB Biotherapeutics)|EV/EBITDA Multiple akaritx.com AKTX|Enlivex Therapeutics Ltd. - EV/EBITDA Multiple|QTTB - EV/EBITDA Multiple|GOVX (GeoVax Labs Inc) - Enterprise Value to EBITDA Ratio|Enterprise Value to EBITDA Ratio Edesa|IBIO (iBio, Inc.) - EV/EBITDA Multiple|CARM: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple XTLB|Enterprise Value to EBITDA Ratio Bolt Biotherapeutics, Inc. BOLT|EV/EBITDA Multiple HCWB (hcwbiologics.com)|Business Value to Operating Income Before Depreciation APVO|AIM ImmunoTech, Inc. - EV/EBITDA Multiple|ADTX (Aditxt Inc.) - Enterprise Value to Operating Income Before Depreciation|GRI: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio ReShape Lifesciences|Enterprise Value to EBITDA Ratio REVB|Indaptus Corp (INDP) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization scinai.com (SCNI)|Enterprise Value to EBITDA Ratio CalciMedica CALI|EV/EBITDA Multiple AFMD (affimed.com)|Allakos Inc. (ALLK) - Company Value to EBITDA|HOOKIPA - EV/EBITDA Multiple|IGMS (igmbio.com) - Enterprise Value to Operating Income Before Depreciation|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation OCEA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC BioPharm|Third Harmonic Bio Inc. (THRD) - Total Company Value to Operating Income Before Depreciation Ratio